Forte Biosciences, Inc. (37T)
XSTU
Real-time Data
06:00 AM
Day's Range
65.5052 wk Range
8.70Overview - 37T - Forte Biosciences, Inc.
Key Statistics
Valuation
P/E (Trailing)
‪-13.90‬
PEG Ratio
‪-13.35‬
Price / Book
‪8.47‬
Profitability
Return on Assets
‪-83.80%‬
Return on Equity
‪-113.74%‬
Ownership
Shares Outstanding
20.48M
Price stats
50-Day Avg
‪47.28‬
200-Day Avg
‪28.23‬
Peers - 37T - Forte Biosciences, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 37TXSTUForte Biosciences, Inc.+86.11%52-week change-13.91P/E (Trailing)—Profit Margin
- 0QFXSTUModerna Inc.+83.17%52-week change-18.38P/E (Trailing)‪54.83%‬Profit Margin
- 3920XSTUSpyre Therapeutics, Inc.+81.45%52-week change-38.38P/E (Trailing)—Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.18%52-week change-84.15P/E (Trailing)‪50.72%‬Profit Margin
- 5NRXSTUNanobiotix S.A.+78.42%52-week change—P/E (Trailing)—Profit Margin
- 3O8XSTUOmeros Corp.+77.40%52-week change-323.00P/E (Trailing)—Profit Margin
- 2LBXSTUIovance Biotherapeutics Inc.+71.95%52-week change-6.33P/E (Trailing)‪34.27%‬Profit Margin
Profile Summary - 37T - Forte Biosciences, Inc.
About
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune and autoimmune-related diseases. The company’s core activity today centers on advancing FB-102, a proprietary anti-CD122 monoclonal antibody designed to modulate immune pathways implicated in conditions…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
